BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8386542)

  • 1. Correlation between clinical staging (FIGO) and prognostic groups with gestational trophoblastic disease.
    Smith DB; Holden L; Newlands ES; Bagshawe KD
    Br J Obstet Gynaecol; 1993 Feb; 100(2):157-60. PubMed ID: 8386542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy.
    Goldstein DP; Zanten-Przybysz IV; Bernstein MR; Berkowitz RS
    J Reprod Med; 1998 Jan; 43(1):37-43. PubMed ID: 9475148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia].
    Wang YX; Zhang X; Guan YL; Jang AY; Long ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):87-90. PubMed ID: 15840285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prognostic factors and staging in gestational trophoblastic tumor.
    Soper JT; Evans AC; Conaway MR; Clarke-Pearson DL; Berchuck A; Hammond CB
    Obstet Gynecol; 1994 Dec; 84(6):969-73. PubMed ID: 7970479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic disease with liver metastases: the Charing Cross experience.
    Crawford RA; Newlands E; Rustin GJ; Holden L; A'Hern R; Bagshawe KD
    Br J Obstet Gynaecol; 1997 Jan; 104(1):105-9. PubMed ID: 8988707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of resistant gestational trophoblastic tumors.
    Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
    J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of prognostic factors in high risk gestational trophoblastic disease with respect to remission and recurrence].
    Matsui H; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):131-7. PubMed ID: 1849542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of treatment relating to gestational trophoblastic tumor registered to the French Trophoblastic Disease Reference Center (TDRC) in Lyon from 1999 to 2005].
    Golfier F; Labrousse C; Frappart L; Mathian B; Guastalla JP; Trillet-Lenoir V; Hajri T; Schott AM; Raudrant D
    Gynecol Obstet Fertil; 2007 Mar; 35(3):205-15. PubMed ID: 17336125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.
    Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ
    Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission rates and significance of prognostic factors in gestational trophoblastic tumors.
    Ayhan A; Yapar EG; Deren O; Kişnişçi H
    J Reprod Med; 1992 May; 37(5):461-5. PubMed ID: 1324312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic staging and risk factor scoring for gestational trophoblastic disease.
    Kohorn EI
    Int J Gynecol Cancer; 2007; 17(5):1124-30. PubMed ID: 17386047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and staging of gestational trophoblastic tumors.
    Miller DS; Lurain JR
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):477-90. PubMed ID: 2852330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the stratification of patients recruited to trials of therapy for low-risk gestational trophoblastic tumor.
    Nevin J; Silcocks P; Hancock B; Coleman R; Nakielny R; Lorigan P
    Gynecol Oncol; 2000 Aug; 78(2):92-6. PubMed ID: 10926786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging and assessing trophoblastic tumors. A possible solution to an intractable problem.
    Kohorn EI
    J Reprod Med; 1998 Jan; 43(1):33-6. PubMed ID: 9475147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors.
    Agarwal R; Strickland S; McNeish IA; Patel DC; Foskett M; Boultbee JE; Newlands ES; Seckl MJ
    Clin Cancer Res; 2002 May; 8(5):1142-7. PubMed ID: 12006530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gestational trophoblastic tumors and recent clinical information].
    Shimizu T; Yaegashi N
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational trophoblastic tumors in Norway, 1968-1997: patient characteristics, treatment, and prognosis.
    Bjørge T; Abeler VM; Sundfør K; Tropé CG; Kaern J
    Gynecol Oncol; 2002 Oct; 87(1):71-6. PubMed ID: 12468345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment.
    Kohorn EI
    Int J Gynecol Cancer; 2001; 11(1):73-7. PubMed ID: 11285037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of risk categorization in gestational trophoblastic tumor between old and new combined staging and scoring system.
    Tocharoenvanich S; Chichareon S; Wootipoom V; Bu-ngachat R; Piyananjarassri K
    J Obstet Gynaecol Res; 2003 Feb; 29(1):20-7. PubMed ID: 12696623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.